Skip to main content

Table 4 IL-2 mean values and standard deviation (SD): difference between treatment group (aVQ) and control group of the 4 visits by independent t -test

From: Quality of life, immunomodulation and safety of adjuvant mistletoe treatment in patients with gastric carcinoma – a randomized, controlled pilot study

 

IL-2 concentration in pg/ml (mean, (SD), median)

t-test

 

aVQ

Control

t

p

Baseline

1.04 (0.56) 0.89

0.94 (0.44) 0.85

−0.5804

0.5662

Visit 2

59.08 (219.95) 0.93

0.76 (0.52) 0.56

−1.0269

0.3219

Visit 3

243.46 (702.12) 0.75

0.55 (0.42) 0.42

−1.3399

0.2016

Visit 4

70.84 (267.49) 0.81

0.46 (0.38) 0.75

−1.0190

0.3255

  1. IL-2: interleukin-2.